Literature DB >> 29090617

Preparation and biological activities of anti-HER2 monoclonal antibodies with fully core-fucosylated homogeneous bi-antennary complex-type glycans.

Wataru Tsukimura1, Masaki Kurogochi2, Masako Mori1, Kenji Osumi2, Akio Matsuda1,2, Kaoru Takegawa3, Kiyoshi Furukawa1, Takashi Shirai1,2.   

Abstract

Recently, the absence of a core-fucose residue in the N-glycan has been implicated to be important for enhancing antibody-dependent cellular cytotoxicity (ADCC) activity of immunoglobulin G monoclonal antibodies (mAbs). Here, we first prepared anti-HER2 mAbs having two core-fucosylated N-glycan chains with the single G2F, G1aF, G1bF, or G0F structure, together with those having two N-glycan chains with a single non-core-fucosylated corresponding structure for comparison, and determined their biological activities. Dissociation constants of mAbs with core-fucosylated N-glycans bound to recombinant Fcγ-receptor type IIIa variant were 10 times higher than those with the non-core-fucosylated N-glycans, regardless of core glycan structures. mAbs with the core-fucosylated N-glycans had markedly reduced ADCC activities, while those with the non-core-fucosylated N-glycans had high activities. These results indicate that the presence of a core-fucose residue in the N-glycan suppresses the binding to the Fc-receptor and the induction of ADCC of anti-HER2 mAbs.

Entities:  

Keywords:  ADCC activity; N-glycans; core-fucosylation; monoclonal antibodies; therapeutic potential

Mesh:

Substances:

Year:  2017        PMID: 29090617     DOI: 10.1080/09168451.2017.1394813

Source DB:  PubMed          Journal:  Biosci Biotechnol Biochem        ISSN: 0916-8451            Impact factor:   2.043


  6 in total

1.  Immunoglobulin G Glycosylation Changes in Aging and Other Inflammatory Conditions.

Authors:  Fabio Dall'Olio; Nadia Malagolini
Journal:  Exp Suppl       Date:  2021

2.  Influence of N-glycosylation on effector functions and thermal stability of glycoengineered IgG1 monoclonal antibody with homogeneous glycoforms.

Authors:  Ryuta Wada; Makoto Matsui; Nana Kawasaki
Journal:  MAbs       Date:  2018-12-10       Impact factor: 5.857

Review 3.  Biosynthesis and Biological Significances of LacdiNAc Group on N- and O-Glycans in Human Cancer Cells.

Authors:  Kiyoko Hirano; Kiyoshi Furukawa
Journal:  Biomolecules       Date:  2022-01-24

4.  Impact of IgG1 N-glycosylation on their interaction with Fc gamma receptors.

Authors:  Florian Cambay; Céline Raymond; Denis Brochu; Michel Gilbert; The Minh Tu; Christiane Cantin; Anne Lenferink; Maxime Grail; Olivier Henry; Gregory De Crescenzo; Yves Durocher
Journal:  Curr Res Immunol       Date:  2020-06-27

5.  TSTA3 facilitates esophageal squamous cell carcinoma progression through regulating fucosylation of LAMP2 and ERBB2.

Authors:  Ling Zhang; Yingzhen Gao; Xiaojuan Zhang; Min Guo; Jie Yang; Heyang Cui; Pengzhou Kong; Xia Niu; Yanghui Bi; Jing Xu; Ting Yan; Yanchun Ma; Jian Yang; Yu Qian; Fang Wang; Hongyi Li; Feng Liu; Xiaolong Cheng; Yongping Cui
Journal:  Theranostics       Date:  2020-09-14       Impact factor: 11.556

6.  Generation of FX-/- and Gmds-/- CHOZN host cell lines for the production of afucosylated therapeutic antibodies.

Authors:  Weiyi Liu; Roshan Padmashali; Omar Quintero Monzon; Dianna Lundberg; Shan Jin; Brian Dwyer; Yun-Jung Lee; Anisha Korde; Sophia Park; Clark Pan; Bohong Zhang
Journal:  Biotechnol Prog       Date:  2020-08-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.